Loading...

Bio-Techne Corporation

TECHNASDAQ
Healthcare
Biotechnology
$58.78
$0.31(0.54%)

Bio-Techne Corporation (TECH) Stock Overview

Explore Bio-Techne Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 76.2/100

Key Financials

Market Cap9.2B
P/E Ratio70.82
EPS (TTM)$0.83
ROE0.06%
Fundamental Analysis

AI Price Forecasts

1 Week$47.93
1 Month$43.45
3 Months$62.07
1 Year Target$69.78

TECH Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Bio-Techne Corporation (TECH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 68.43, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $69.78.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 70.82 and a market capitalization of 9.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;